The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress
Abstract
The receptor for advanced glycation end products (RAGE) may promote diabetic vascular and renal disease through the activation of intracellular signaling pathways that promote oxidative stress. Oxidative stress is a mediator of hyperglycemia-induced cell injury and a unifying theme for all mechanisms of diabetic complications, but there are few studies on the expression and potential contribution of RAGE in diabetic neuropathy. The current study demonstrates that dorsal root ganglia neurons express functional RAGE and respond to the RAGE ligand S100 with similar downstream signaling, oxidative stress, and cellular injury as other diabetic complication-prone tissues. RAGE-induced phosphatidylinositol-3 kinase activity is associated with formation of reactive oxygen species, caspase-3 activation, and nuclear DNA degradation. These events are prevented by treatment with the antioxidant alpha-lipoic acid. Our data indicate that therapies aimed at decreasing RAGE ligands, blocking RAGE signaling, or preventing oxidative stress could significantly decrease the development of neuropathy in diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Vincent, A. M., Russell, J. W., Low, P., & Feldman, E. L. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0019 · Cited by 982
Self-citationDiabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Protein Glycation, Diabetes, and Aging
Ulrich, P. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.1 · Cited by 810
Quagliaro, L., Piconi, L., Assaloni, R., Martinelli, L., Motz, E., & Ceriello, A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2795 · Cited by 769
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Hydrogen Peroxide: A Key Messenger That Modulates Protein Phosphorylation Through Cysteine Oxidation
Rhee, S. G., Bae, Y. S., Lee, S.-R., & Kwon, J. (2000) · Science's STKE · doi:10.1126/stke.2000.53.pe1 · Cited by 644
Wendt, T. M., Tanji, N., Guo, J., Kislinger, T. R., Qu, W., Lu, Y., Bucciarelli, L. G., Rong, L. L., Moser, B., Markowitz, G. S., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63909-0 · Cited by 600
Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525
High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons
Russell, J. W., Golovoy, D., Vincent, A. M., Mahendru, P., Olzmann, J. A., Mentzer, A., & Feldman, E. L. (2002) · The FASEB Journal · doi:10.1096/fj.01-1027com · Cited by 520
Self-citationTANJI, N., MARKOWITZ, G. S., FU, C., KISLINGER, T., TAGUCHI, A., PISCHETSRIEDER, M., STERN, D., SCHMIDT, A. M., & D'AGATI, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 487
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Neurons Undergo Apoptosis in Animal and Cell Culture Models of Diabetes
Russell, J. W., Sullivan, K. A., Windebank, A. J., Herrmann, D. N., & Feldman, E. L. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0254 · Cited by 411
Self-citationRegulation of PDGF signalling and vascular remodelling by peroxiredoxin II
Choi, M. H., Lee, I. K., Kim, G. W., Kim, B. U., Han, Y.-H., Yu, D.-Y., Park, H. S., Kim, K. Y., Lee, J. S., Choi, C., et al. (2005) · Nature · doi:10.1038/nature03587 · Cited by 403
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
Self-citationCentral role of RAGE-dependent neointimal expansion in arterial restenosis
Sakaguchi, T., Yan, S. F., Yan, S. D., Belov, D., Rong, L. L., Sousa, M., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17115 · Cited by 367
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 301
Rage: A Novel Cellular Receptor for Advanced Glycation End Products
Schmidt, A. M., Hori, O., Cao, R., Yan, S. D., Brett, J., Wautier, J.-L., Ogawa, S., Kuwabara, K., Matsumoto, M., & Stern, D. (1996) · Diabetes · doi:10.2337/diab.45.3.s77 · Cited by 299
Short‐term hyperglycemia produces oxidative damage and apoptosis in neurons
Vincent, A. M., Mclean, L. L., Backus, C., & Feldman, E. L. (2005) · The FASEB Journal · doi:10.1096/fj.04-2513fje · Cited by 295
Self-citationControl of cell survival by IGF signaling pathways
Vincent, A. M., & Feldman, E. L. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00017-5 · Cited by 289
Self-citationROS Generation by Nonphagocytic NADPH Oxidase: Potential Relevance in Diabetic Nephropathy
Li, J.-M., & Shah, A. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077406.67663.e7 · Cited by 288
Negative consequences of glycation
Brownlee, M. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80078-5 · Cited by 284
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Li, J. H., Huang, X. R., Zhu, H., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., & Lan, H. Y. (2004) · The FASEB Journal · doi:10.1096/fj.02-1117fje · Cited by 264
Oxidative stress and diabetic neuropathy: a new understanding of an old problem
Feldman, E. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17862 · Cited by 244
Self-citationGlycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options
Thornalley, P. J. (2002) · International Review of Neurobiology · doi:10.1016/s0074-7742(02)50072-6 · Cited by 243
Huang, J.-S., Guh, J.-Y., Chen, H.-C., Hung, W.-C., Lai, Y.-H., & Chuang, L.-Y. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1<102::aid-jcb1027>3.0.co;2-y · Cited by 225
Soulis, T., Thallas, V., Youssef, S., Gilbert, R. E., McWilliam, B. G., Cooper, M. E., & Murray-McIntosh, R. P. (1997) · Diabetologia · doi:10.1007/s001250050725 · Cited by 222
Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., & Kasaoka, T. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00846-9 · Cited by 201
Ellenberg and Rifkinʼs Diabetes Mellitus: Theory and Practice
Rifkin, H., Porte, D., & Gallon, D. J. (1992) · The Endocrinologist · doi:10.1097/00019616-199203000-00012 · Cited by 195
Shanmugam, N., Kim, Y. S., Lanting, L., & Natarajan, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302828200 · Cited by 192
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
Kilhovd, B. K., Giardino, I., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Thornalley, P. J., Brownlee, M., & Hanssen, K. F. (2003) · Metabolism · doi:10.1053/meta.2003.50035 · Cited by 187
Insulin-like Growth Factors Regulate Neuronal Differentiation and Survival
Feldman, E. L., Sullivan, K. A., Kim, B., & Russell, J. W. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0156 · Cited by 187
Self-citationUncoupling Proteins Prevent Glucose-Induced Neuronal Oxidative Stress and Programmed Cell Death
Vincent, A. M., Olzmann, J. A., Brownlee, M., Sivitz, W. I., & Russell, J. W. (2004) · Diabetes · doi:10.2337/diabetes.53.3.726 · Cited by 178
Self-citationThe role of growth factors in diabetic peripheral neuropathy
Leinninger, G. M., Vincent, A. M., & Feldman, E. L. (2004) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2004.09105.x · Cited by 170
Self-citationHudson, B. I., Bucciarelli, L. G., Wendt, T., Sakaguchi, T., Lalla, E., Qu, W., Lu, Y., Lee, L., Stern, D. M., Naka, Y., et al. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.030 · Cited by 165
Decreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients
Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T., Sakamoto, K., Nakatani, Y., Ohtoshi, K., Hayaishi-Okano, R., Kosugi, K., Hori, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2716 · Cited by 155
Leinninger, G. M., Backus, C., Uhler, M. D., Lentz, S. I., & Feldman, E. L. (2004) · The FASEB Journal · doi:10.1096/fj.04-1581fje · Cited by 153
Self-citationDifferential effects between amphoterin and advanced glycation end products on colon cancer cells
Kuniyasu, H., Chihara, Y., & Kondo, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11016 · Cited by 150
IGF-I prevents glutamate-induced motor neuron programmed cell death
Vincent, A. M., Mobley, B. C., Hiller, A., & Feldman, E. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.001 · Cited by 148
Self-citationRong, L., Yan, S., Wendt, T., Hans, D., Pachydaki, S. I., Bucciarelli, L. G., Adebayo, A., Qu, W., Lu, Y., Kostov, K., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1900com · Cited by 148
Schalkwijk, C. G., Ligtvoet, N., Twaalfhoven, H. A. M., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2446 · Cited by 147
The role of glycation in the pathogenesis of diabetic polyneuropathy
King, R. H. M. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.400 · Cited by 136
Li, B., Setoguchi, M., Wang, X., Andreoli, A. M., Leri, A., Malhotra, A., Kajstura, J., & Anversa, P. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1007 · Cited by 134
Pathogenesis of Diabetic Neuropathy
Stevens, M. J., Feldman, E. L., Thomas, T. P., & Greene, D. A. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1816-6_2 · Cited by 131
Self-citationCotter, M. A., & Cameron, N. E. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00508-3 · Cited by 123
Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons.
Koliatsos, V. E., Cayouette, M. H., Berkemeier, L. R., Clatterbuck, R. E., Price, D. L., & Rosenthal, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3304 · Cited by 120
Enhanced Expression of Receptor for Advanced Glycation End Products in Chronic Kidney Disease
Hou, F. F., Ren, H., Owen, W. F., Guo, Z. J., Chen, P. Y., Schmidt, A. M., Miyata, T., & Zhang, X. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131526.99506.f7 · Cited by 114
Dukić-Stefanović, S., Gasic‐Milenkovic, J., Deuther‐Conrad, W., & Münch, G. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01988.x · Cited by 105
Sasaki, N., Takeuchi, M., Chowei, H., Kikuchi, S., Hayashi, Y., Nakano, N., Ikeda, H., Yamagishi, S., Kitamoto, T., Saito, T., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00310-5 · Cited by 105
Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 90
RAGE Expression and AGE-Induced MAP Kinase Activation in Caco-2 Cells
Zill, H., Günther, R., Erbersdobler, H. F., Fölsch, U. R., & Faist, V. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5901 · Cited by 89
Molecular Mechanism for Activation of Superoxide-producing NADPH Oxidases
Takeya, R., & Sumimoto, H. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13800-3 · Cited by 88
Shaw, S., Schmidt, A. M., Banes, A. K., Wang, X., Stern, D. M., & Marrero, M. B. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2381 · Cited by 83
RAGE-mediated MAPK activation by food-derived AGE and non-AGE products
Zill, H., Bek, S., Hofmann, T. F., Huber, J., Frank, O., Lindenmeier, M., Weigle, B., Erbersdobler, H. F., Scheidler, S., Busch, A. E., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02856-5 · Cited by 71
Roles of the AGE‐RAGE System in Vascular Injury in Diabetesa
Yamamoto, Y., Yamagishi, S., Yonekura, H., Doi, T., Tsuji, H., KATO, I., Takasawa, S., OKAMOTO, H., Abedin, J., Tanaka, N., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06311.x · Cited by 69
Matsunaga-Irie, S., Maruyama, T., Yamamoto, Y., Motohashi, Y., Hirose, H., Shimada, A., Murata, M., & Saruta, T. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.303 · Cited by 68
Cell Culture Modeling to Test Therapies Against Hyperglycemia-Mediated Oxidative Stress and Injury
Vincent, A. M., Stevens, M. J., Backus, C., McLean, L. L., & Feldman, E. L. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1494 · Cited by 63
Self-citationXu, D., & Kyriakis, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302771200 · Cited by 61
Bartling, B., Demling, N., Silber, R., & Simm, A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0194oc · Cited by 59
Fan, C., Katsuyama, M., Nishinaka, T., & Yabe‐Nishimura, C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.021 · Cited by 57
Haslbeck, K.-M., Bierhaus, A., Erwin, S., Kirchner, A., Nawroth, P. P., Schlötzer, U., Neundörfer, B., & Heuß, D. F. (2004) · Muscle & Nerve · doi:10.1002/mus.20039 · Cited by 56
Poolman, T. M., Ng, L. L., Farmer, P. B., & Manson, M. M. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.036 · Cited by 56
Ma, L., Carter, R. J., Morton, A. J., & Nicholson, L. F. B. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04149-5 · Cited by 50
Layton, B. E., & Sastry, A. M. (2004) · Journal of Biomechanical Engineering · doi:10.1115/1.1824118 · Cited by 42
Self-citationKim, B., Leventhal, P. S., White, M. F., & Feldman, E. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6348 · Cited by 41
Self-citationYoung, M. R., Kolesiak, K., & Meisinger, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10491 · Cited by 38
Layton, B. E., Sastry, A. M., Wang, H., Sullivan, K. A., Feldman, E. L., Komorowski, T. E., & Philbert, M. A. (2004) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2003.11.008 · Cited by 32
Self-citationWang, H., Layton, B. E., & Sastry, A. M. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.372 · Cited by 30
Self-citationDownregulation of IRS-1 protein in thapsigargin-treated human prostate epithelial cells
Zhang, H., Hoff, H. B., & Sell, C. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00286-6 · Cited by 15
In Situ Imaging of Mitochondrial Outer-Membrane Pores using Atomic Force Microscopy
Layton, B. E., Sastry, A. M., Lastoskie, C. M., Philbert, M. A., Miller, T. J., Sullivan, K. A., Feldman, E. L., & Wang, C.-W. (2004) · BioTechniques · doi:10.2144/04374bi01 · Cited by 15
Self-citationNonenzymatic glycosylation of DNA by reducing sugars.
At, L., & Cerami, A. (1989) · PubMed · Cited by 10
Cited by
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Self-citationDiabetic neuropathy: clinical manifestations and current treatments
Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70065-0 · Cited by 1,211
Self-citationDiabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Self-citationS100B's double life: Intracellular regulator and extracellular signal
Donato, R., Sorci, G., Riuzzi, F., Arcuri, C., Bianchi, R., Brozzi, F., Tubaro, C., & Giambanco, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.009 · Cited by 731
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Self-citation
Metadata
- Authors
- Vincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., & Feldman, E. L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-02
- Volume
- 148
- Issue
- 2
- Pages
- 548-558
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2112841292
- Cited by
- 258
- References
- 79
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.